| By Dishman Group |
| Thursday, 18 February 2010 |
 |
Today, the Dishman Group announced the formation
of a strategic alliance with Codexis, Inc. a California
|
|
based biotechnology company. This strategic partnership covers the use of Codexis’ proprietary enzymatic biocatalysis technology for the manufacture of building blocks, intermediates and APIs for innovator pharmaceutical companies.
Dishman will be a preferred contract manufacturer for Codexis and will be able to offer the technology to its own customers.
In addition, the companies will work exclusively on certain select accounts.
Codexis offers a wide selection of enzymes for the pharmaceutical synthesis of chiral compounds. With |
|
|
the majority of today’s drugs containing at least one chiral centre, this technology is directed
at the very heart of pharmaceutical manufacture.
In comparison to traditional chemical synthesis,
this technology offers a number of significant advantages:
cost reduction compared with
conventional complex transformations as a result of telescoped processes, increased specificity
gives improved yields and often improved impurity profiles, significant reduction in environmental
impact through reduce use of organic solvents and reduced energy processes.
This alliance will benefit Codexis and its customers by enabling Codexis to offer production of both intermediates and final APIs in Dishman’s world-class manufacturing |
|
asset base.
“We are
delighted to be working with Codexis on this innovative technology. It adds another dimension to
the already extensive portfolio of services offered by the Dishman Group.
Our customers will
benefit from cheaper, cleaner, greener processes manufactured in a low cost environment, a
significant differentiator given today’s regulatory and market conditions ” said Nick Green,
President Dishman CRAMS.
Want to read more?
Former Schering & Plough CEO speaks out about the pharmaceutical Industry
CARBOGEN AMCIS AG Opens New High-Potency Manufacturing Unit
Meeting Tight OEL Limits In API Milling
|
|
|
